OUR TEAM

Gentronix Ltd. comprises a team of people who are passionate about the science of toxicology. Combined, we have decades of experience within predictive toxicology space and the SME environment and together we are committed to delivering the highest quality science, in an effective and efficient manner.

A WEALTH OF EXPERIENCE

MATT TATE
MATT TATEManaging Director
Matt has been with the business since 2006. Initially working on the development of our screening assays and earning a PhD in genetic toxicology, Matt transitioned to the commercial side of the business, working globally with clients to implement the most appropriate testing strategies for their needs. He now leads the business, developing our overall strategy and delivering our plan to build an expert predictive toxicology CRO, whilst remaining passionate about toxicology and engaging with our clients to meet their challenges.
NICK BILLINTON
NICK BILLINTONChief Scientific Officer
Nick is one of the company’s originating scientists, initially as a PhD student in the founding lab. Post-PhD, Nick led the research efforts to develop the GreenScreen® HC & BlueScreen™ HC technologies, and then the transition of the business to a CRO. Providing project management and scientific leadership, Nick implemented GLP compliance in the organisation. As Operations Director, Nick continues to ensure our commitment to expert delivery of high quality science is maintained.
LAURA HINTON
LAURA HINTONChief Operating Officer
Laura joined Gentronix in 2020 as an Operations Director to work towards delivering ambitious growth plans as part of the senior leadership team. During the early stages of her career Laura worked as a DMPK scientist in a leading pharmaceutical company and gained a PhD in pharmacokinetics. It was the transition into a role in a specialist CRO that led to Laura developing an interest in the operational aspects of the CRO business and latterly becoming their Director of Scientific Operations. With over 15 years of contract research experience, Laura’s interests now lie in the development and scaling of effective organisations to enable sustainable growth and timely delivery of high quality services.
DEREK MCFERRAN
DEREK MCFERRANCommercial Director
Derek joined Gentronix in 2023 to lead the commercial efforts of the business. Derek has a career of more than 20yrs in the life science sector in a variety of senior operational and commercial roles and is experienced in building successful sales teams. Derek has a degree in Molecular Biology from University of Glasgow and a PhD in Endocrinology from University of Manchester.
DARRYL WHITEChief Financial Officer
Darryl is Gentronix’s Chief Financial Officer, equipped with a strong financial background and a wealth of experience in the industry. Prior to Gentronix, he held finance management positions for FMCG and life science organisations such as LGC, Kellogg’s and AstraZeneca. Darryl’s skills, experience and commitment to excellence allow him to greatly contribute to the team’s continued success.
LUCINDA LILLFORDHead of Genetic Toxicology
Lucinda is the Head of Genetic Toxicology at Gentronix, leading our genetic toxicology lab teams with over 20 years of experience in regulatory genotox. Lucinda is an expert in her field and a dedicated mentor. She is passionate about guiding and nurturing emerging scientists, ensuring dynamic and engaging career paths in genetic toxicology.
ELIAS HALKES-WELLSTEAD
ELIAS HALKES-WELLSTEADSenior Business Development Manager
Elias joined Gentronix in 2020 as a Business Development Manager, having previously worked in sales development within a genomic stabilisation devices company in Canada. Following the completion of his Masters in Genetic Toxicology and experience in the micronucleus assay and benchmark dose response analysis, Elias is well positioned to assist clients in assay selection in both a GLP and Non-GLP framework.
SIMRIT ATTWALBusiness Development Manager
Simrit joined the Gentronix Business Development team in 2024, with a Masters in Toxicology and over 8 years of experience in driving business growth for GLP CROs and chemical consultancies. Her proven ability to provide dedicated support makes her the ideal person to assist our clients in the chemical industry with their regulatory testing and screening.
PAIGE BEALE
PAIGE BEALEBusiness Development Manager
Paige joined Gentronix as a Business Development Manager in 2024. With roots as a technician in genetic toxicology, her career has evolved through roles as a Pharmacology Study Director to her most recent position as a Project Manager in Cardiac Safety. Paige’s extensive background and commitment to scientific excellence makes her well-qualified to support our pharmaceutical and biotech clients with their regulatory genotox needs.
LYDIA EARL
LYDIA EARLBusiness Development Associate
Lydia joined the company in 2023 after graduating from the University of Manchester in Biology with Science and Society. With extensive customer service experience from her years in a variety of hospitality roles, combined with her scientific training, Lydia is well-equipped to support our global client base with their genotoxicity needs as a Business Development Associate.

OUR VALUES

OUR VALUES

Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.

We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.

This is guided by our core values, which we apply to all the studies we perform:

  • Excellence; we strive to deliver the highest quality service using the most appropriate scientific tools.

  • Effectiveness; we aim to deliver high quality results when you need them.

  • Efficiency; we optimise our approach to deliver maximum data from minimum material.

  • Engagement; we engage scientifically to support study design through to data interpretation and management.

Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.

We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.

This is guided by our core values, which we apply to all the studies we perform:

  • Excellence; we strive to deliver the highest quality service using the most appropriate scientific tools.

  • Effectiveness; we aim to deliver high quality results when you need them.

  • Efficiency; we optimise our approach to deliver maximum data from minimum material.

  • Engagement; we engage scientifically to support study design through to data interpretation and management.

Genetic Toxicology Services

Icon of a laboratory flask, symbolizing Gentronix’s services in genetic toxicology screening.

Genetic Toxicology Screening

We offer a broad range of rapid turnaround screens, focussed on low test item usage, to detect and contextualise genotoxic liability early in development.

Clipboard icon denoting Gentronix's regulatory genotoxicity studies, highlighting organisation and documentation in testing.

Regulatory Genotoxicity Studies

We offer various GLP in vitro and in vivo genotoxicity studies that allow clients to demonstrate chemical safety and address their regulatory requirements.

Icon showing a shield with multiple layers of skin, representing skin toxicology services at Gentronix.

Skin Toxicology

Providing corrosion, irritation and skin sensitisation assays, we enable a comprehensive assessment of dermal toxicology potential.

Flow cytometer icon used to denote Gentronix's flow cytometry services, essential for detailed cellular analysis.

Flow Cytometry Services

Working with our clients, we utilise our flow cytometry experience and expertise to deliver a diverse range of endpoints.

Your Trusted Partner in Genotoxicity and Toxicology Services